KeyBanc Cuts Acadia Healthcare (ACHC) PT to $30 from $35, Maintains Overweight on Q3 Results

Group 1 - Acadia Healthcare Company Inc. is considered a cheap stock to buy according to analysts, with KeyBanc lowering its price target to $30 from $35 while maintaining an Overweight rating [1][3] - In Q3 2025, Acadia Healthcare reported a revenue increase of 4.4%, totaling $851.6 million, supported by a 3% growth in same facility admissions [2][3] - The company's adjusted EBITDA for Q3 decreased to $173 million from $194.3 million in the prior year, leading to a reduction in Adjusted EBITDA guidance for 2025 to a range of $650 to $660 million [3]